CLINICAL_TRIALS
trial_result
· 2014-11-03
Clinical Trial Update: A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 1]
Summary
Phase 1b study of IV PRM151 in idiopathic pulmonary fibrosis has completed; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2014-11-03